Bioheart, Inc. Announces Additional Funding Support
October 17, 2008 17:00 ET
|
Bioheart, Inc.
SUNRISE, Fla., Oct. 17, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc., (Nasdaq:BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
Bioheart, Inc. Reports Receipt of Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
October 17, 2008 16:57 ET
|
Bioheart, Inc.
SUNRISE, Fla., Oct. 17, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) today announced that it received a letter from the Nasdaq Stock Market (the "Nasdaq Letter") on October 15, 2008 advising...
Bioheart Announces Pricing of Initial Public Offering and Commencement of Trading
February 19, 2008 13:15 ET
|
Bioheart, Inc.
SUNRISE, Fla., Feb. 19, 2008 (PRIME NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today the pricing of its initial public offering of 1,100,000 shares of common stock at a price of $5.25 per...
Bioheart, Inc. Appoints William H. Pinon President and CEO
March 07, 2007 09:37 ET
|
Bioheart, Inc.
SUNRISE, Fla., March 7, 2007 (PRIME NEWSWIRE) -- Bioheart, Inc., a biotechnology company focused on the discovery, development and commercialization of cell-based therapies and related devices, for...
Bioheart, Inc. Provides Unrestricted Research Grant to the Ohio Cell-Based Therapy Consortium
February 26, 2007 17:09 ET
|
Bioheart, Inc.
SUNRISE, Fla. and CLEVELAND, Feb. 26, 2007 (PRIME NEWSWIRE) -- Bioheart, Inc., a biotechnology company focused on the development of innovative cell therapies for the treatment of heart attacks,...